肝细胞移植联合肝再生增强因子治疗大鼠急性肝功能衰竭的研究

王志毅; 张艳; 石小枫; 刘杞

您当前的位置：

首页 >

文章列表页 >

肝细胞移植联合肝再生增强因子治疗大鼠急性肝功能衰竭的研究

论著 | 更新时间：2026-01-09

- 肝细胞移植联合肝再生增强因子治疗大鼠急性肝功能衰竭的研究
- Combining hepatocyte transplantation intraperitoneally and augmenter of liver regeneration for acute hepatic failure in rats
- 陆军军医大学学报 2007年29卷第10期页码：899-902
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R575.305;R657.3;R977.6
- 纸质出版：2007
- 稿件说明：
移动端阅览
王志毅,张艳,石小枫,刘杞.肝细胞移植联合肝再生增强因子治疗大鼠急性肝功能衰竭的研究[J].陆军军医大学学报(原第三军医大学学报),2007,29(10):899-902.

　WANG Zhi-yi,ZHANG Yan,SHI Xiao-feng,LIU Qi.Combining hepatocyte transplantation intraperitoneally and augmenter of liver regeneration for acute hepatic failure in rats[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(10):899-902.
王志毅,张艳,石小枫,刘杞.肝细胞移植联合肝再生增强因子治疗大鼠急性肝功能衰竭的研究[J].陆军军医大学学报(原第三军医大学学报),2007,29(10):899-902. DOI：

　WANG Zhi-yi,ZHANG Yan,SHI Xiao-feng,LIU Qi.Combining hepatocyte transplantation intraperitoneally and augmenter of liver regeneration for acute hepatic failure in rats[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(10):899-902. DOI：

摘要

目的探讨同种异体肝细胞腹腔移植联合肝再生增强因子（augmenter of liver regenration

ALR）对D-氨基半乳糖(D-gal)诱导的急性肝功能衰竭大鼠的治疗作用。方法采用D-gal诱导大鼠急性肝功能衰竭，诱导后24 h，59只大鼠随机数字表法分成4组。Ⅰ组15只：腹腔注射生理盐水；Ⅱ组15只：经腹腔移植2×10

肝细胞

以后腹腔注射生理盐水；Ⅲ组15只：经腹腔移植2×10

肝细胞，同时腹腔注射ALR 50 μg·kg

-1

·d

-1

；Ⅳ组14只：腹腔注射ALR50 μg·kg

-1

·d

-1

。观察大鼠的存活率、肝脏功能、移植肝细胞存活情况、病理变化。结果 Ⅱ组、Ⅲ组大鼠存活率(46.7%、66.7%)显著高于Ⅰ组(0.0%)(P=0.006；P=0.0002)，Ⅲ组(66.7%)与Ⅳ组(14.3%)有显著差异(P=0.008)，其他组间无明显差异(P0.05)。移植后第1、2天Ⅱ组腹水AST高于Ⅲ组（P=0.001）

Ⅱ组第1、2天腹水ALT高于Ⅳ组，Ⅱ组、Ⅲ组第1、2天腹水TBil高于Ⅰ组（P0.05）。Ⅲ组肝脏病理改变轻于其他组。Ⅲ组大鼠腹腔移植的肝细胞存活数多于Ⅱ组。结论同种异体肝细胞经腹腔移植联合ALR可明显改善D-gal诱导的肝衰竭大鼠的存活率，促进移植肝细胞存活和增殖，促进肝组织及功能恢复。

Abstract

Objective To investigate the effect of allogeneic hepatocyte transplantation (HcT) plus augmenter of liver regenration (ALR) intraperitoneally on acute hepatic failure (AHF) induced by D-galactosamine (D-gal) in rats. Methods AHF was induced by D-gal in SD rats. HcT was received 24 h after intoxication

and the AHF rats were divided into four groups randomly. Group Ⅰ receiv

ed normal saline (NS) intraperitoneally. Group Ⅱ received 2×10

hepatocytes intraperitoneally and daily NS. Group Ⅲ received 2×10

hepatocytes intraperitoneally and daily intraperitoneal injection of ALR (50 μg·kg

-1

·d

-1

) simultaneously. Group Ⅳ received daily intraperitoneal injection of ALR (50 μg·kg

-1

·d

-1

). The survival rate of rats

the survival rate of transplanted hepatocytes

liver function and liver histology of all rats were observed. Results Survival rate of Group Ⅱ

Group Ⅲ was higher than that of GroupⅠ(46.7%

66.7% vs 0.0%

P=0.006

P=0.000 2)

that of Group Ⅲ was higher than Group Ⅳ (66.7% vs 14.3%

P=0.008)

without significant difference among other groups. Ascitic aspartate aminotransferase (AST) of Group Ⅱ was higher than that of Group Ⅲ on day 1

2 after transplantation (P=0.001). Ascitic alanine aminotransferase (ALT) of Group Ⅱ was higher than that of Group Ⅳ on day 1

2 after transplantation (P0.05). Ascitic total bilirubin of Group Ⅱ

Group Ⅲ was higher than that of GroupⅠ (P0.05). Hepatic histologic changes of Group Ⅲ was improved more than other groups. The function and histologic changes of transplanted hepatocytes were obviously improved in Group Ⅲ as compared with that of Group Ⅱ. Conclusion After HcT plus ALR intraperitoneally

the survival rate of AHF rats intoxicated with D-gal was increased

and their liver function and histologic changes were also improved. ALR improved the survival and proliferation of transplanted hepatocytes.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据